Reductive metabolism of tiaprofenic acid by the human liver and recombinant carbonyl reducing enzymes
Language English Country Ireland Media print-electronic
Document type Journal Article
PubMed
28322780
DOI
10.1016/j.cbi.2017.03.006
PII: S0009-2797(17)30303-4
Knihovny.cz E-resources
- Keywords
- AKR, Carbonyl reducing enzymes (CREs), Carbonyl reductase, Reductive drug metabolism, Short-chain dehydrogenase/reductase, Tiaprofenic acid,
- MeSH
- Alcohol Oxidoreductases chemistry genetics metabolism MeSH
- Biocatalysis MeSH
- Cytosol enzymology MeSH
- Short Chain Dehydrogenase-Reductases chemistry genetics metabolism MeSH
- Liver enzymology metabolism MeSH
- Kinetics MeSH
- Humans MeSH
- Microsomes enzymology MeSH
- Propionates chemistry metabolism MeSH
- Recombinant Proteins biosynthesis chemistry isolation & purification MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Alcohol Oxidoreductases MeSH
- CBR1 protein, human MeSH Browser
- Short Chain Dehydrogenase-Reductases MeSH
- Propionates MeSH
- Recombinant Proteins MeSH
- tiaprofenic acid MeSH Browser
Tiaprofenic acid is a widely used anti-inflammatory drug; however, the reductive metabolism of tiaprofenic acid is not yet well understood. Here, we compared the reduction of tiaprofenic acid in microsomes and cytosol from the human liver. The microsomes exhibited lower Km value toward tiaprofenic acid than the cytosol (Km = 164 ± 18 μM vs. 569 ± 74 μM, respectively), whereas the cytosol showed higher specific activity during reduction than the microsomes (Vmax = 728 ± 52 pmol mg of protein-1 min-1 vs. 285 ± 11 pmol mg of protein-1 min-1, respectively). Next, a panel of recombinant carbonyl reducing enzymes from AKR and SDR superfamilies has been studied to find the enzymes responsible for the cytosolic reduction of tiaprofenic acid. CBR1 was identified as the reductase of tiaprofenic acid with high specific activity (56,965 ± 6741 pmol mg of protein-1 min-1). Three other enzymes, AKR1A1, AKR1B10, and AKR1C4, were also able to reduce tiaprofenic acid, but with very low activity. Thus, CBR1 was shown to be a tiaprofenic acid reductase in vitro and was also suggested to be the principal tiaprofenic acid reductase in vivo.
References provided by Crossref.org